Who Buys Lomustine from India — 135 Importers Behind a $103.3K Market
India's lomustine import market is served by 135 active buyers who collectively imported $103.3K across 399 shipments. THE ESSES PHARMACY (PVT) LTD (SRI LANKA) leads with a 9.9% market share, followed by TO THE IMPORT MANAGER and TO THE IMPORTING DEPARTMENT. The top 5 buyers together control 22.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Lomustine Importers — Ranked by Import Value
THE ESSES PHARMACY (PVT) LTD (SRI LANKA) is the leading lomustine importer from India, holding a 9.9% share of the $103.3K market across 399 shipments from 135 buyers. The top 5 buyers — THE ESSES PHARMACY (PVT) LTD (SRI LANKA), TO THE IMPORT MANAGER (UNITED ARAB EMIRATES), TO THE IMPORTING DEPARTMENT (ITALY), TO THE CONSIGNEE- (POLAND), SKIN LINE LOGISTIC (IRAQ) — collectively control 22.3% of total import value.
Top Lomustine Buyers & Importers
Ranked by import value · 135 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | THE ESSES PHARMACY (PVT) LTDSRI LANKA LOMOOTHER CAPLOMUSTINE CAPSULES IP 40MGLOMUSTINE CAPSULE IP 40 MG TOTAL | $10.3K | 5 | 9.9% |
| 2 | TO THE IMPORT MANAGERUNITED ARAB EMIRATES LOMOOTHER 40MG CAPSULESBELUSTINE 40BELUSTINE 40MG LOMUSTINE IP / 40MG BATCHNO: CLMSA1501 | $5.7K | 5 | 5.5% |
| 3 | TO THE IMPORTING DEPARTMENTITALY LOMOOTHER 40MG CAPSULESBELUSTINE 40BELUSTINE 40MG LOMUSTINE IP / 40MG BATCHNO: CLMSA1501 | $2.6K | 5 | 2.5% |
| 4 | TO THE CONSIGNEE-POLAND LOMOOTHER 40MG CAPSULESBELUSTINE 40BELUSTINE 40MG LOMUSTINE IP / 40MG BATCHNO: CLMSA1501 | $2.3K | 5 | 2.2% |
| 5 | SKIN LINE LOGISTICIRAQ | $2.2K | 5 | 2.1% |
| 6 | TO THE, IMPORTING DEPARTMENT,SWITZERLAND LOMOOTHER 40MG CAPSULESBELUSTINE 40BELUSTINE 40MG LOMUSTINE IP / 40MG BATCHNO: CLMSA1501 | $2.2K | 5 | 2.1% |
| 7 | TO THE CONSIGNEEMALAYSIA LOMOOTHER 40MG CAPSULESBELUSTINE 40BELUSTINE 40MG LOMUSTINE IP / 40MG BATCHNO: CLMSA1501 | $2.0K | 5 | 1.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Lomustine — and from which countries?
Flow of Lomustine exports from India: each country's share and the named importers behind the numbers
Lomustine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Italy
Italy emerges as the first largest importing country, achieving a total trade value of $13.3K through 16 shipments. This represents a market share of 12.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Italy has a diverse importer base, with their top importers including:
• TO THE IMPORTING DEPARTMENT - $2.6K (19.8% of country's total business)
Key Insight: Italy demonstrates strong market positioning with an average shipment value of $829, indicating premium pricing strategy compared to the market average of $259.
Italy is a key market for Lomustine imports, representing 12.8% of total trade value.
2Brazil
Brazil emerges as the second largest importing country, achieving a total trade value of $12.8K through 0 shipments. This represents a market share of 12.4% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $12.8K, indicating premium pricing strategy compared to the market average of $259.
Brazil is a key market for Lomustine imports, representing 12.4% of total trade value.
3Sri Lanka
Sri Lanka emerges as the third largest importing country, achieving a total trade value of $10.6K through 3 shipments. This represents a market share of 10.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• THE ESSES PHARMACY (PVT) LTD - $10.3K (97.1% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $3.5K, indicating premium pricing strategy compared to the market average of $259.
Sri Lanka is a key market for Lomustine imports, representing 10.2% of total trade value.
4Pakistan
Pakistan emerges as the fourth largest importing country, achieving a total trade value of $9.1K through 0 shipments. This represents a market share of 8.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Pakistan demonstrates strong market positioning with an average shipment value of $9.1K, indicating premium pricing strategy compared to the market average of $259.
Pakistan is a key market for Lomustine imports, representing 8.8% of total trade value.
5United Arab Emirates
United Arab Emirates emerges as the fifth largest importing country, achieving a total trade value of $8.2K through 3 shipments. This represents a market share of 7.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Arab Emirates has a diverse importer base, with their top importers including:
• TO THE IMPORT MANAGER - $5.7K (69.5% of country's total business)
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $2.7K, indicating premium pricing strategy compared to the market average of $259.
United Arab Emirates is a key market for Lomustine imports, representing 7.9% of total trade value.
Buyer Segment Analysis
TransData Nexus Lomustine buyer market intelligence
1Buyer Segment Analysis
The importation of Lomustine from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like THE ESSES PHARMACY (PVT) LTD in Sri Lanka and TO THE IMPORT MANAGER in the United Arab Emirates function as intermediaries, procuring Lomustine in bulk to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by large, periodic orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as TO THE IMPORTING DEPARTMENT in Italy and TO THE CONSIGNEE- in Poland represent hospital networks that import Lomustine directly for patient treatment. Their procurement is driven by patient demand and treatment protocols, leading to regular, sizable orders.
- Retail Chains: Entities like SKIN LINE LOGISTIC in Iraq and TO THE CONSIGNEE in Malaysia are retail pharmacy chains that import Lomustine to meet consumer demand. Their purchasing behavior includes frequent, smaller orders to ensure product availability while managing inventory levels.
- Re-exporters: Companies such as TO THE, IMPORTING DEPARTMENT, in Switzerland may act as re-exporters, importing Lomustine for redistribution to other markets. Their order patterns are influenced by global demand fluctuations and trade agreements.
Each segment's procurement strategy is tailored to their operational needs, balancing factors like demand forecasting, inventory management, and regulatory compliance.
Country-Specific Import Regulations
TransData Nexus Lomustine buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Lomustine in the top importing countries is crucial:
- Italy:
- Regulatory Authority: Italian Medicines Agency (Agenzia Italiana del Farmaco - AIFA).
- Import Registration Process: Requires submission of a Marketing Authorization Application (MAA) to AIFA, including comprehensive data on quality, safety, and efficacy.
- Estimated Timeline: Approximately 210 days, subject to completeness of the application.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are typically exempt from import duties within the European Union.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária - ANVISA).
- Import Registration Process: Submission of a registration dossier to ANVISA, including technical documentation and compliance with Good Manufacturing Practices (GMP).
- Estimated Timeline: Varies, generally between 6 to 12 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 14% import duty.
- Sri Lanka:
- Regulatory Authority: National Medicines Regulatory Authority (NMRA).
- Import Registration Process: Submission of an application to NMRA, including product details, manufacturing information, and evidence of registration in the country of origin.
- Estimated Timeline: Approximately 6 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally exempt from import duties.
- Pakistan:
- Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).
- Import Registration Process: Submission of a registration application to DRAP, including product specifications, clinical data, and GMP certification.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
- United Arab Emirates:
- Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- Import Registration Process: Submission of a registration dossier to MOHAP, including product information, manufacturing details, and proof of registration in the country of origin.
- Estimated Timeline: Approximately 6 to 9 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are typically exempt from import duties.
Compliance with these regulatory frameworks is essential for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Lomustine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Lomustine in importing countries is influenced by several factors:
- Disease Prevalence: Lomustine is primarily used in the treatment of certain types of brain tumors and Hodgkin's lymphoma. The incidence rates of these conditions directly impact the demand for this medication.
- Government Healthcare Programs: Initiatives aimed at improving cancer care, such as national cancer control programs, increase the accessibility and affordability of treatments like Lomustine.
- Universal Health Coverage Expansion: Countries expanding their health coverage ensure that a larger segment of the population has access to essential medicines, thereby boosting demand.
- WHO Essential Medicines List Procurement: Inclusion of Lomustine in the WHO Model List of Essential Medicines encourages its procurement by member countries, aligning with global health priorities.
- Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, ensuring competitive pricing and consistent supply of essential medicines like Lomustine.
With 135 buyers across 36 countries, the market for Lomustine demonstrates a broad and diverse demand base, presenting significant opportunities for suppliers.
Common Questions — Lomustine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest lomustine buyer importing from India?
Based on import volume and value, THE ESSES PHARMACY (PVT) LTD (SRI LANKA) leads with $10.3K in imports and a 9.9% market share — the highest of any single lomustine importer. TO THE IMPORT MANAGER (UNITED ARAB EMIRATES) and TO THE IMPORTING DEPARTMENT (ITALY) are the next largest buyers.
QHow many companies buy lomustine from India?
There are 135 active lomustine buyers importing from India, with a combined market of $103.3K across 399 shipments to 36 countries. The top 5 buyers hold 22.3% of total import value, while the remaining 130 buyers handle the other 77.7%.
QWhich countries import the most lomustine from India?
The top importing countries for lomustine from India are Italy (12.8%), Brazil (12.4%), Sri Lanka (10.2%), Pakistan (8.8%), United Arab Emirates (7.9%). These markets represent the largest demand centres for Indian pharmaceutical exports of lomustine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for lomustine from India?
The average import transaction value for lomustine from India is $259, with an average unit price of $18.67 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Lomustine buyer market intelligence
1Buyer Segment Analysis
The importation of Lomustine from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like THE ESSES PHARMACY (PVT) LTD in Sri Lanka and TO THE IMPORT MANAGER in the United Arab Emirates function as intermediaries, procuring Lomustine in bulk to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by large, periodic orders to maintain a steady supply chain.
- Hospital Groups: Organizations such as TO THE IMPORTING DEPARTMENT in Italy and TO THE CONSIGNEE- in Poland represent hospital networks that import Lomustine directly for patient treatment. Their procurement is driven by patient demand and treatment protocols, leading to regular, sizable orders.
- Retail Chains: Entities like SKIN LINE LOGISTIC in Iraq and TO THE CONSIGNEE in Malaysia are retail pharmacy chains that import Lomustine to meet consumer demand. Their purchasing behavior includes frequent, smaller orders to ensure product availability while managing inventory levels.
- Re-exporters: Companies such as TO THE, IMPORTING DEPARTMENT, in Switzerland may act as re-exporters, importing Lomustine for redistribution to other markets. Their order patterns are influenced by global demand fluctuations and trade agreements.
Each segment's procurement strategy is tailored to their operational needs, balancing factors like demand forecasting, inventory management, and regulatory compliance.
Country-Specific Import Regulations
TransData Nexus Lomustine buyer market intelligence
1Country-Specific Import Regulations
Understanding the import regulations for Lomustine in the top importing countries is crucial:
- Italy:
- Regulatory Authority: Italian Medicines Agency (Agenzia Italiana del Farmaco - AIFA).
- Import Registration Process: Requires submission of a Marketing Authorization Application (MAA) to AIFA, including comprehensive data on quality, safety, and efficacy.
- Estimated Timeline: Approximately 210 days, subject to completeness of the application.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are typically exempt from import duties within the European Union.
- Brazil:
- Regulatory Authority: National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária - ANVISA).
- Import Registration Process: Submission of a registration dossier to ANVISA, including technical documentation and compliance with Good Manufacturing Practices (GMP).
- Estimated Timeline: Varies, generally between 6 to 12 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 14% import duty.
- Sri Lanka:
- Regulatory Authority: National Medicines Regulatory Authority (NMRA).
- Import Registration Process: Submission of an application to NMRA, including product details, manufacturing information, and evidence of registration in the country of origin.
- Estimated Timeline: Approximately 6 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are generally exempt from import duties.
- Pakistan:
- Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).
- Import Registration Process: Submission of a registration application to DRAP, including product specifications, clinical data, and GMP certification.
- Estimated Timeline: Approximately 12 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are subject to a 5% import duty.
- United Arab Emirates:
- Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- Import Registration Process: Submission of a registration dossier to MOHAP, including product information, manufacturing details, and proof of registration in the country of origin.
- Estimated Timeline: Approximately 6 to 9 months.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30049099 are typically exempt from import duties.
Compliance with these regulatory frameworks is essential for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Lomustine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Lomustine in importing countries is influenced by several factors:
- Disease Prevalence: Lomustine is primarily used in the treatment of certain types of brain tumors and Hodgkin's lymphoma. The incidence rates of these conditions directly impact the demand for this medication.
- Government Healthcare Programs: Initiatives aimed at improving cancer care, such as national cancer control programs, increase the accessibility and affordability of treatments like Lomustine.
- Universal Health Coverage Expansion: Countries expanding their health coverage ensure that a larger segment of the population has access to essential medicines, thereby boosting demand.
- WHO Essential Medicines List Procurement: Inclusion of Lomustine in the WHO Model List of Essential Medicines encourages its procurement by member countries, aligning with global health priorities.
- Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, ensuring competitive pricing and consistent supply of essential medicines like Lomustine.
With 135 buyers across 36 countries, the market for Lomustine demonstrates a broad and diverse demand base, presenting significant opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 135 global importers of Lomustine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 399 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 36 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
399 Verified Shipments
135 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists